Immune Response to SARS-CoV-2 Vaccines

COVID-19 vaccines have been developed to confer immunity against the SARS-CoV-2 infection. Prior to the pandemic of COVID-19 which started in March 2020, there was a well-established understanding about the structure and pathogenesis of previously known Coronaviruses from the SARS and MERS outbreaks...

Descripción completa

Detalles Bibliográficos
Autores principales: Bellamkonda, Navya, Lambe, Upendra Pradeep, Sawant, Sonali, Nandi, Shyam Sundar, Chakraborty, Chiranjib, Shukla, Deepak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312515/
https://www.ncbi.nlm.nih.gov/pubmed/35884770
http://dx.doi.org/10.3390/biomedicines10071464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312515/
https://www.ncbi.nlm.nih.gov/pubmed/35884770
http://dx.doi.org/10.3390/biomedicines10071464

Ejemplares similares